Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Leah Calder

Physician Assistant Vicksburg, MS Physician Assistant

NPI 1063479608 CMS profile 10584409

188 Ymca Pl, Vicksburg, MS 39183

Open in the dashboard

General payments

$7,875

435 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leah Calder of Vicksburg, MS is reported in the CMS Open Payments database as having received $7,875 across 435 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $650 36
2024 General $1,462 58
2023 General $2,146 123
2022 General $1,971 118
2021 General $1,646 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leah Calder
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Leah Calder were reported at $650. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Leah Calder Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,646 $132 $37–$438 $132
2022 $1,971 $155 $48–$522 $149
2023 $2,146 $167 $52–$557 $160
2024 $1,462 $178 $55–$600 $164
2025 $650 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,731 130 payments
  2. Sun Pharmaceutical Industries Inc. $824 30 payments
  3. Novartis Pharmaceuticals Corporation $703 58 payments
  4. Regeneron Healthcare Solutions, Inc. $577 28 payments
  5. Lilly USA, LLC $430 22 payments
  6. Janssen Biotech, Inc. $418 17 payments
  7. UCB, Inc. $372 21 payments
  8. Incyte Corporation $369 23 payments
  9. LEO Pharma Inc. $321 18 payments
  10. Amgen Inc. $299 15 payments
  11. Other $1,831 73 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,464 430 payments
  2. Education $412 5 payments
Products named General payments · program years 2021–2025
  1. RINVOQ $947 68 payments
  2. SKYRIZI $756 49 payments
  3. DUPIXENT $557 27 payments
  4. TALTZ $404 21 payments
  5. OPZELURA $369 23 payments
  6. Winlevi $335 15 payments
  7. TREMFYA $309 11 payments
  8. COSENTYX $300 27 payments
  9. Cimzia $265 16 payments
  10. Otezla $264 13 payments
  11. Other $4,573 239 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

206

Median for Physician Assistant: 241

Drug cost

$3,124

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 40 $773
Clobetasol Propionate Generic 16 $759
Triamcinolone Acetonide Generic 62 $727
Doxycycline Hyclate Generic 57 $641
Spironolactone Generic 17 $185
Prednisone Generic 14 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$34,978

Medicare's payments for the services billed

Medicare patients

222

Average age 76

Services billed

857

126 women, 96 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 27%
Ischemic heart disease 24%
Atrial fibrillation 20%
Depression 19%
Chronic kidney disease 18%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 18 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $246
$246 — —
RINVOQ
  • AbbVie, Inc. $152
$152 — —
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $125
$125 — —
SKYRIZI
  • AbbVie, Inc. $123
$123 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $79
  • GENZYME CORPORATION $37
$116 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 18 in the dashboard with a free account

Records

435 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record